FDA Inspection 1220016 — Karen L. Kotloff, MD
The FDA completed an inspection of Karen L. Kotloff, MD on September 15, 2023 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 15, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Baltimore, MD (United States)
Additional Details
Sponsor-Investigator (S-I)